Skip to content

Arjun Agarwal, Senior Vice President, Finance at Oruka Therapeutics, sold ORKA on Sep 11, 2026

Data as of Oct 16

▼ SELL$374K4,051 shares at $92.41Arjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.
Watch ORKA
Traded
Sep 11, 2026
Disclosed
Sep 15, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Arjun Agarwal, Senior Vice President, Finance at Oruka Therapeutics, sold ORKA on Sep 11, 2026TRADEDDISCLOSED
ORKASimilar stocks (XLV — its sector index fund), rebased to ORKA's price on the disclosure day
ORKA since disclosure
−22.0%
after the sale
Similar stocks (XLV) since disclosure
+5.4%
XLV — its sector index fund

Change in closing price from Sep 15, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$53.6Kdisclosed Sep 15 · filed the same day
  2. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$18.8Kdisclosed Sep 15 · filed 4 days after the trade
  3. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$206Kdisclosed Sep 15 · filed 4 days after the trade
  4. ▼ SELLArjun Agarwal Senior Vice President, FinanceORKA Oruka Therapeutics, Inc.$273Kdisclosed Sep 15 · filed 4 days after the trade

See every trade on ORKA →